HAL
48
-3
SBUX
37
-2
JWN
48
-2
STI
45
26
UAL
83
-2
FRT
41
-2
MLM
45
-5
LUV
45
-2
FTI
71
-7
EQR
54
3
CAH
48
-6
KR
36
-6
TGT
45
-4
CSX
57
-4
STT
64
2
TGNA
50
-6
KMI
69
-2
CNP
54
10
THC
60
-5
AMAT
33
-13
HAL
48
-3
SBUX
37
-2
JWN
48
-2
STI
45
26
UAL
83
-2
FRT
41
-2
MLM
45
-5
LUV
45
-2
FTI
71
-7
EQR
54
3
CAH
48
-6
KR
36
-6
TGT
45
-4
CSX
57
-4
STT
64
2
TGNA
50
-6
KMI
69
-2
CNP
54
10
THC
60
-5
AMAT
33
-13
Financhill
Back

PT Bank Rakyat Indonesia (Persero) Tbk Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
38

BKRKF
PT Bank Rakyat Indonesia (Persero) Tbk

Last Price:
0.25
Seasonality Move:
8.63%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
38
PT Bank Rakyat Indonesia (Persero) Tbk (BKRKF) is a Sell

Is PT Bank Rakyat Indonesia (Persero) Tbk a Buy, Sell or Hold?

  • The current PT Bank Rakyat Indonesia (Persero) Tbk [BKRKF] share price is $0.25. The Score for BKRKF is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • BKRKF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BKRKF Stock Price Chart

What is PT Bank Rakyat Indonesia (Persero) Tbk's stock price today?

  • The PT Bank Rakyat Indonesia (Persero) Tbk share price today is $0.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BKRKF is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

BKRKF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 36.4 Sell
Chaikin Money Flow: -17761 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.26 - 0.3) Sell
Bollinger Bands (100): (0.27 - 0.33) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

BKRKF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.27 Sell
20-day SMA: 0.28 Sell
50-day SMA: 0.3 Sell
200-day SMA: 0.31 Sell
8-day EMA: 0.27 Sell
20-day EMA: 0.28 Sell
50-day EMA: 0.29 Sell
200-day EMA: 0.31 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

PT Bank Rakyat Indonesia (Persero) Tbk Earnings Growth & BKRKF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

PT Bank Rakyat Indonesia (Persero) Tbk Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):